Joseph L Witztum
University of California, San Diego
H-index: 169
North America-United States
Top articles of Joseph L Witztum
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury | 2024/2/13 | ||
Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia | The New England journal of medicine | Veronica J Alexander Ewa Karwatowska-Prokopczuk Thomas A Prohaska Lu Li Richard S Geary | 2024/2/1 |
Oxidized Phospholipid Neutralizing Antibody Ameliorates Pulmonary Fibrosis | E Sajti W Tang X Sun J Witztum C Glass | 2022/5 | |
Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome | The New England Journal of Medicine | Erik SG Stroes Veronica J Alexander Ewa Karwatowska-Prokopczuk Robert A Hegele Marcello Arca | 2024/4/7 |
A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME | Journal of the American College of Cardiology | Erik SG Stroes Vickie Alexander Ewa Prokopczuk Robert Hegele Marcello Arca | 2024/4/2 |
Oxidized phospholipids in cardiovascular disease | Sotirios Tsimikas Joseph L Witztum | 2024/3 | |
High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction | Journal of lipid research | Adam Taleb Peter Willeit Shahzada Amir Thomas Perkmann Maria Ozsvar Kozma | 2023/6/1 |
FRI092 Rationale And Design Of The Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Olezarsen In Patients With Familial Chylomicronemia Syndrome | Journal of the Endocrine Society | Veronica Alexander Ewa Karwatowska-Prokopczuk Erik SG Stroes Christie Ballantyne Henry N Ginsberg | 2023/10 |
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia | Journal of Clinical Lipidology | Thomas A Prohaska Veronica J Alexander Ewa Karwatowska-Prokopczuk Joseph Tami Shuting Xia | 2023/4/27 |
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia | Atherosclerosis | T Prohaska V Alexander E Karwatowska-Prokopczuk J Tami S Xia | 2023/8/1 |
Host-derived oxidized phospholipids initiate effector-triggered immunity fostering lethality upon microbial encounter | bioRxiv | Marco Di Gioia Valentina Poli Piao J Tan Roberto Spreafico Anne Chu | 2023/11/21 |
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial | Journal of clinical lipidology | Joseph L Witztum Daniel Gaudet Marcello Arca Alan Jones Handrean Soran | 2023/5/1 |
On-treatment platelet reactivity through the thromboxane A2 or P2Y12 platelet receptor pathways is not affected by pelacarsen | Journal of Thrombosis and Thrombolysis | Ewa Karwatowska-Prokopczuk Lu Li Jun Yang Joseph L Witztum Sotirios Tsimikas | 2023/8 |
Therapies and methods to treat tlr2-mediated diseases and disorders | 2023/11/9 | ||
Apolipoprotein C3 induces inflammasome activation only in its delipidated form | Nature immunology | Cheng-Chieh Hsu Baohai Shao Jenny E Kanter Yi He Tomas Vaisar | 2023/3 |
Rationale and Design of the Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen in Patients with Familial Chylomicronemia Syndrome | Journal of Clinical Lipidology | Ewa Karwatowska-Prokopczuk Veronica Alexander Erik SG Stroes Christie M Ballantyne Henry N Ginsberg | 2023/7/1 |
Antibodies to oxidized phospholipids | 2023/11/9 | ||
Isoform-independent antibodies to lipoprotein (a) | 2023/6/1 | ||
Corrigendum to “Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial … | Journal of Clinical Lipidology | Joseph L Witztum Daniel Gaudet Marcello Arca Alan Jones Handrean Soran | 2023/10/13 |
Effect of pelacarsen on lipoprotein (a) cholesterol and corrected low-density lipoprotein cholesterol | Journal of the American College of Cardiology | Calvin Yeang Ewa Karwatowska-Prokopczuk Fei Su Brian Dinh Shuting Xia | 2022/3/22 |